Published in Proc Natl Acad Sci U S A on March 30, 1999
Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol (2002) 4.77
A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length. Proc Natl Acad Sci U S A (2004) 3.21
Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci (2004) 3.13
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A (2002) 2.82
When cells get stressed: an integrative view of cellular senescence. J Clin Invest (2004) 2.37
Ku is associated with the telomere in mammals. Proc Natl Acad Sci U S A (1999) 2.36
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev (2006) 2.20
N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Mol Cell Biol (2001) 2.16
Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol (2001) 1.99
Natural and pharmacological regulation of telomerase. Nucleic Acids Res (2002) 1.92
Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci U S A (2001) 1.87
Engineered telomere degradation models dyskeratosis congenita. Genes Dev (2008) 1.72
Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc Natl Acad Sci U S A (2001) 1.69
Dynamics of telomerase activity in response to acute psychological stress. Brain Behav Immun (2009) 1.68
DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J (2004) 1.58
Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres. Mol Cell (2007) 1.56
Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita. Mol Cell Biol (2008) 1.46
C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity. Mol Cell Biol (2002) 1.46
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation. Proc Natl Acad Sci U S A (2001) 1.43
Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol Cell Biol (2000) 1.42
Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc Natl Acad Sci U S A (2002) 1.38
A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci U S A (2008) 1.37
Mediterranean diet, telomere maintenance and health status among elderly. PLoS One (2013) 1.15
Telomere length is reset during early mammalian embryogenesis. Proc Natl Acad Sci U S A (2004) 1.14
Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell. World J Gastroenterol (2002) 1.12
Sensitivity of yeast strains with long G-tails to levels of telomere-bound telomerase. PLoS Genet (2007) 1.12
Telomerase can act as a template- and RNA-independent terminal transferase. Proc Natl Acad Sci U S A (2005) 1.12
A conserved telomerase motif within the catalytic domain of telomerase reverse transcriptase is specifically required for repeat addition processivity. Mol Cell Biol (2003) 1.11
Putative telomere-recruiting domain in the catalytic subunit of human telomerase. Mol Cell Biol (2003) 1.09
Transcriptional silencing of a novel hTERT reporter locus during in vitro differentiation of mouse embryonic stem cells. Mol Biol Cell (2006) 1.09
Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell (2010) 1.07
Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J (2010) 1.07
Separation of telomerase functions by reverse genetics. Proc Natl Acad Sci U S A (2011) 1.07
The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization. Nucleic Acids Res (2009) 1.05
Cellular Senescence: Ex Vivo p53-Dependent Asymmetric Cell Kinetics. J Biomed Biotechnol (2001) 1.04
Recombination-based telomere maintenance is dependent on Tel1-MRN and Rap1 and inhibited by telomerase, Taz1, and Ku in fission yeast. Mol Cell Biol (2007) 1.04
Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein. Hum Genet (2003) 1.04
Telomerase RNA template mutations reveal sequence-specific requirements for the activation and repression of telomerase action at telomeres. Mol Cell Biol (2000) 1.03
Analysis of telomerase in Candida albicans: potential role in telomere end protection. Eukaryot Cell (2002) 1.03
Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria. Front Oncol (2012) 1.02
Telomerase core components protect Candida telomeres from aberrant overhang accumulation. Proc Natl Acad Sci U S A (2007) 1.01
Rearrangement of upstream sequences of the hTERT gene during cellular immortalization. Genes Chromosomes Cancer (2009) 1.00
Hostility and cellular aging in men from the Whitehall II cohort. Biol Psychiatry (2011) 0.99
The role of telomerase expression and telomere length maintenance in human and mouse. J Clin Immunol (2000) 0.97
G-quadruplexes in viruses: function and potential therapeutic applications. Nucleic Acids Res (2014) 0.95
Differential repression of human and mouse TERT genes during cell differentiation. Nucleic Acids Res (2009) 0.95
Essential role for mammalian apurinic/apyrimidinic (AP) endonuclease Ape1/Ref-1 in telomere maintenance. Proc Natl Acad Sci U S A (2013) 0.94
Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT. Blood (2005) 0.94
Strategies for immortalization of primary hepatocytes. J Hepatol (2014) 0.93
Regulation of cellular immortalization and steady-state levels of the telomerase reverse transcriptase through its carboxy-terminal domain. Mol Cell Biol (2006) 0.93
Crisis intervention: the role of telomerase. Proc Natl Acad Sci U S A (1999) 0.93
Molecular targeting of cancer: telomeres as targets. Proc Natl Acad Sci U S A (2001) 0.93
Dual roles of c-Myc in the regulation of hTERT gene. Nucleic Acids Res (2014) 0.92
An alternative telomerase RNA in Arabidopsis modulates enzyme activity in response to DNA damage. Genes Dev (2012) 0.92
Events in the immortalizing process of primary human mammary epithelial cells by the catalytic subunit of human telomerase. Biochem J (2002) 0.91
Telomerase expression is sufficient for chromosomal integrity in cells lacking p53 dependent G1 checkpoint function. J Carcinog (2005) 0.90
HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes. PLoS Pathog (2013) 0.90
Immortalization of a primate bipotent epithelial liver stem cell. Proc Natl Acad Sci U S A (2002) 0.88
Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Curr Cardiol Rev (2008) 0.88
Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma. Neoplasia (2010) 0.88
Involvement of telomerase reverse transcriptase in heterochromatin maintenance. Mol Cell Biol (2014) 0.85
Inhibition of telomerase by linear-chain fatty acids: a structural analysis. Biochem J (2002) 0.84
Increased telomerase activity and vitamin D supplementation in overweight African Americans. Int J Obes (Lond) (2011) 0.84
Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response. Nucleic Acids Res (2012) 0.83
Therapeutic targeting of replicative immortality. Semin Cancer Biol (2015) 0.83
Strict control of telomerase activation using Cre-mediated inversion. BMC Biotechnol (2006) 0.82
Human Telomerase Reverse Transcriptase (hTERT) Transcription Requires Sp1/Sp3 Binding to the Promoter and a Permissive Chromatin Environment. J Biol Chem (2015) 0.81
IFN-α inhibits telomerase in human CD8⁺ T cells by both hTERT downregulation and induction of p38 MAPK signaling. J Immunol (2013) 0.81
Telomerase prevents accelerated senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. J Biomed Sci (2009) 0.80
Role for telomerase in Listeria monocytogenes infection. Infect Immun (2012) 0.79
Inducible transgenics. New lessons on events governing the induction and commitment in mammary tumorigenesis. Breast Cancer Res (2001) 0.79
Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1. Br J Cancer (2003) 0.78
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation. Oncotarget (2016) 0.77
The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression. J Carcinog (2004) 0.77
Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE. Mol Cancer (2010) 0.77
There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer. Int Semin Surg Oncol (2004) 0.77
Abundance of a distinct cluster of telomere t-stumps in advanced breast cancer cell line. Oncol Lett (2010) 0.76
New prospects for targeting telomerase beyond the telomere. Nat Rev Cancer (2016) 0.76
The Rap1p-telomere complex does not determine the replicative capacity of telomerase-deficient yeast. Mol Cell Biol (2003) 0.75
Enhancement of extra chromosomal recombination in somatic cells by affecting the ratio of homologous recombination (HR) to non-homologous end joining (NHEJ). Anim Biotechnol (2008) 0.75
Generation and characterization of feline arterial and venous endothelial cell lines for the study of the vascular endothelium. BMC Vet Res (2013) 0.75
Telomere homeostasis in mammalian germ cells: a review. Chromosoma (2015) 0.75
The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters. Int Semin Surg Oncol (2006) 0.75
Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes. FASEB J (2016) 0.75
A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus. Mol Cancer Ther (2015) 0.75
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25.11
Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell (1997) 13.34
Telomerase catalytic subunit homologs from fission yeast and human. Science (1997) 12.35
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97
A survey of telomerase activity in human cancer. Eur J Cancer (1997) 10.84
The RNA component of human telomerase. Science (1995) 9.86
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74
Telomere length regulation. Annu Rev Biochem (1996) 6.98
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet (1997) 6.69
Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J (1995) 6.03
Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev (1998) 5.14
Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (1997) 4.97
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol (1998) 4.59
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci U S A (1998) 4.11
A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res (1991) 4.07
Reconstitution of human telomerase activity in vitro. Curr Biol (1998) 3.51
Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev (1997) 3.47
Functional characterization and developmental regulation of mouse telomerase RNA. Science (1995) 3.26
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet (1998) 3.01
Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev (1996) 2.76
Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med (1996) 2.60
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet (1998) 2.56
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene (1998) 2.56
Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci U S A (1998) 2.40
Functionally interacting telomerase RNAs in the yeast telomerase complex. Genes Dev (1997) 2.37
Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc Natl Acad Sci U S A (1998) 2.27
Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet (1996) 2.18
Activation of telomerase in a human tumor. Proc Natl Acad Sci U S A (1994) 2.11
Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun (1991) 2.10
Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res (1989) 1.96
Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc Natl Acad Sci U S A (1986) 1.70
Severe growth defect in mouse cells lacking the telomerase RNA component. Nat Genet (1998) 1.64
In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A (1997) 1.58
Mapping the transcriptional transactivation function of simian virus 40 large T antigen. J Virol (1991) 1.47
Telomeres, telomerase and cancer. Sci Am (1996) 1.40
Telomerase activity in normal and malignant murine tissues. Oncogene (1995) 1.34
Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay. Nucleic Acids Res (1997) 1.32
Identification of Kluyveromyces lactis telomerase: discontinuous synthesis along the 30-nucleotide-long templating domain. Mol Cell Biol (1998) 1.22
Inducible gene expression by DNA rearrangements in human cells. Mol Cell Biol (1986) 1.19
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol (1985) 25.52
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell (1985) 24.17
Structure and function of telomeres. Nature (1991) 14.82
Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell (1978) 13.33
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature (1989) 13.18
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein. Cell (1978) 11.17
Correct integration of retroviral DNA in vitro. Cell (1987) 10.73
Cellular oncogenes and retroviruses. Annu Rev Biochem (1983) 10.65
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature (1976) 9.81
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (1984) 9.64
Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature (1982) 9.12
A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev (1989) 8.80
The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell (1987) 8.32
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (1983) 8.18
Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc Natl Acad Sci U S A (1989) 8.13
Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell (1999) 8.03
The molecular genetics of cancer. Science (1987) 7.64
Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src). Proc Natl Acad Sci U S A (1979) 7.55
The molecular structure of centromeres and telomeres. Annu Rev Biochem (1984) 7.51
Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites. Cell (1978) 7.46
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med (2000) 7.38
Molecular cloning and characterization of avian sarcoma virus circular DNA molecules. J Virol (1980) 7.37
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest (2001) 7.20
Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci U S A (1983) 7.01
Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state. Cell (1981) 6.98
An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell (1993) 6.89
In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature (1990) 6.82
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61
DNA sequences of telomeres maintained in yeast. Nature (1984) 6.52
A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol (1978) 6.45
Cloning yeast telomeres on linear plasmid vectors. Cell (1982) 6.39
Virus-specific ribonucleic acid in cells producing rous sarcoma virus: detection and characterization. J Virol (1972) 6.38
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med (1999) 6.27
Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell (1982) 6.19
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science (1997) 6.10
Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A (1996) 6.00
Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues. Mol Cell Biol (1982) 5.70
Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol (1987) 5.67
Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell (1996) 5.45
Retroviruses. Annu Rev Biochem (1978) 5.41
The size and genetic composition of virus-specific RNAs in the cytoplasm of cells producing avian sarcoma-leukosis viruses. Cell (1977) 5.23
Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product. Nature (1980) 5.22
Viral oncogenes. Cell (1985) 5.20
Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev (1998) 5.14
Purification of DNA complementary to nucleotide sequences required for neoplastic transformation of fibroblasts by avian sarcoma viruses. J Mol Biol (1976) 5.07
The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane. Proc Natl Acad Sci U S A (1980) 4.99
Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J (1997) 4.99
The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J (1991) 4.96
Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine-guanine base pairs. Cell (1987) 4.85
HMG-1 as a mediator of acute lung inflammation. J Immunol (2000) 4.78
Telomeres and their control. Annu Rev Genet (2000) 4.74
Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). Proc Natl Acad Sci U S A (1981) 4.69
Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (1989) 4.65
The low molecular weight RNAs of Rous sarcoma virus. I. The 4 S RNA. Virology (1970) 4.64
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proc Natl Acad Sci U S A (2001) 4.62
Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science (1999) 4.61
Location and function of retroviral and SV40 sequences that enhance biochemical transformation after microinjection of DNA. Cell (1983) 4.53
A conserved secondary structure for telomerase RNA. Cell (1991) 4.52
Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates. Proc Natl Acad Sci U S A (1978) 4.47
c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature (2001) 4.46
Runaway telomere elongation caused by telomerase RNA gene mutations. Nature (1995) 4.34
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature (1985) 4.31
Integration of deoxyribonucleic acid specific for Rous sarcoma virus after infection of permissive and nonpermissive hosts. Proc Natl Acad Sci U S A (1973) 4.19
A joint produce of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase. Cell (1977) 4.18
The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci U S A (1998) 4.17
Evolutionary analyses of the human genome. Nature (2001) 4.13
Gene expression profiles during the initial phase of salt stress in rice. Plant Cell (2001) 4.11
Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell (1977) 4.06
Structural and functional domains of the Rous sarcoma virus transforming protein (pp60src). Proc Natl Acad Sci U S A (1981) 4.04
Kinetics of synthesis, structure and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells. J Mol Biol (1978) 4.04
The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine. J Biol Chem (1980) 3.95
Transcription of DNA from the 70S RNA of Rous sarcoma virus. I. Identification of a specific 4S RNA which serves as primer. J Virol (1974) 3.90
Functional evidence for an RNA template in telomerase. Science (1990) 3.88
A candidate protein kinase C gene, PKC1, is required for the S. cerevisiae cell cycle. Cell (1990) 3.87
Identification of nuclear proteins encoded by viral and cellular myc oncogenes. Nature (1984) 3.86
Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. Proc Natl Acad Sci U S A (1981) 3.82
Quantum ground state and single-phonon control of a mechanical resonator. Nature (2010) 3.71
Computer-based screening system for patients at risk of hypothyroidism. Lancet (1969) 3.70
DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J Virol (1979) 3.68
Ethidium bromide inhibits appearance of closed circular viral DNA and integration of virus-specific DNA in duck cells infected by avian sarcoma virus. Nature (1975) 3.63
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med (1999) 3.57
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature (1983) 3.56
Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus. Cell (1982) 3.53
Purification and characterization of the deoxyribonucleic acid polymerase associated with Rous sarcoma virus. Biochemistry (1972) 3.53
Daily requirement of oxygen to reverse pulmonary hypertension in patients with chronic bronchitis. Br Med J (1972) 3.43
Corrections to the nucleotide sequence of the src gene of Rous sarcoma virus. Nature (1983) 3.42
Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc Natl Acad Sci U S A (1983) 3.41
Production of mouse mammary tumor virus by cultured cells in the absence and presence of hormones: assay by molecular hybridization. Virology (1975) 3.40
Telomerase in yeast. Science (1995) 3.38
A cellular protein that associates with the transforming protein of Rous sarcoma virus is also a heat-shock protein. Proc Natl Acad Sci U S A (1981) 3.32
RNA-directed DNA polymerase of Rous sarcoma virus: initiation of synthesis with 70 S viral RNA as template. J Mol Biol (1973) 3.32
The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci U S A (1984) 3.31
Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: increased rate of synthesis of viral RNA. Proc Natl Acad Sci U S A (1977) 3.31
Detection of avian tumor virus-specific nucleotide sequences in avian cell DNAs (reassociation kinetics-RNA tumor viruses-gas antigen-Rous sarcoma virus, chick cells). Proc Natl Acad Sci U S A (1972) 3.28
Requirement for math5 in the development of retinal ganglion cells. Genes Dev (2001) 3.26
A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature (1997) 3.26
Alternative gene form discovery and candidate gene selection from gene indexing projects. Genome Res (1998) 3.26